| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/24/2005 | US20050044597 Wheat plants having increased resistance to imidazolinone herbicides |
| 02/24/2005 | US20050044596 Methods to confer enhanced floral properties to plants |
| 02/24/2005 | US20050044595 In planta transformation by embryo imbibition of agrobacterium |
| 02/24/2005 | US20050044594 Method for modifying plant morphology, biochemistry and physiology |
| 02/24/2005 | US20050044593 Chloroplast transformation of duckweed |
| 02/24/2005 | US20050044592 Plant growth modulation |
| 02/24/2005 | US20050044591 Plant cell cycle genes and methods of use |
| 02/24/2005 | US20050044590 Methods and means for altering fiber characteristics in fiber-producing plants |
| 02/24/2005 | US20050044589 Process for preparing an anti-oxidant in a plant by transformation with glucan lyase DNA |
| 02/24/2005 | US20050044588 Methods and substances for preventing and treating autoimmune disease |
| 02/24/2005 | US20050044586 Recombinant promoter drives tissue-specific expression of heterologous nucleic acid molecule in floral organ; improved fragrance and color |
| 02/24/2005 | US20050044585 Plants with enhanced levels of nitrogen utilization proteins in their root epidermis and uses thereof |
| 02/24/2005 | US20050044584 LKB1 gene knockout animals |
| 02/24/2005 | US20050044582 Novel polynucleotides and uses therefor |
| 02/24/2005 | US20050044581 Animals and cells containing a mutated alpha2/omega1 gene |
| 02/24/2005 | US20050044578 Rat highly sensitive to carcinogen |
| 02/24/2005 | US20050044406 Adaptive behavioral intrusion detection systems and methods |
| 02/24/2005 | US20050043530 Seminal vesicle tissue-specific promoters and uses thereof |
| 02/24/2005 | US20050043528 Enterococcus faecalis polynucleotides and polypeptides |
| 02/24/2005 | US20050043526 Sigma factor A (SIGA) protein for use as tool in expression of operons associated with lysine biosynthesis; ennhancing animal feeds; cosmetics; medicine |
| 02/24/2005 | US20050043525 Nucleotide sequences coding amidotransferase for use in identifying modulator for use in identifying microbiocides, fungicides and/or herbicidal agents |
| 02/24/2005 | US20050043524 Modulation of diacylglycerol acyltransferase 2 expression |
| 02/24/2005 | US20050043519 Generating immunoglobulin specific to novel antigen receptor (NAR) for use in innunodiagnostic and immunotherapy |
| 02/24/2005 | US20050043518 Monoclonal antibody for use in detection of plant protein associated with natural rubber; diagnosing latex allergies and hypersensitivity |
| 02/24/2005 | US20050043516 TACI antibodies and uses thereof |
| 02/24/2005 | US20050043514 Monoclonal antibody recognizing phosphatidylinositol-3,4-diphosphate |
| 02/24/2005 | US20050043513 Nucleotide sequences coding olfactory receptor protein for use in pest control, cosmetics, deodorants and treatment and prevention of disorders associated with loss of smell |
| 02/24/2005 | US20050043512 Human glioma antigen originating in testis |
| 02/24/2005 | US20050043511 G-protein coupled receptor lustr2 and uses thereof |
| 02/24/2005 | US20050043510 Immobilization on matrix; fusion proteins; high throughput assay; kits |
| 02/24/2005 | US20050043330 Antiinflammation agents |
| 02/24/2005 | US20050043297 Farnesyl dibenzodiazepinone, processes for its production and its use as a pharmaceutical |
| 02/24/2005 | US20050043267 Methods and compositions for inhibiting the function of polynucleotide sequences |
| 02/24/2005 | US20050043266 Hepatitis virus C genome is a single-stranded RNA that functions as both a messenger RNA and replication template, making it an attractive target for the study of RNA interference; double-stranded short interfering RNA molecules designed to target the HCV genome |
| 02/24/2005 | US20050043265 High affinity RNA ligands of basic fibroblast growth factor |
| 02/24/2005 | US20050043263 First stretch is complementary to the nucleic acid coding for functional tumor suppressor for which the pathological cell is tumor suppressor-defective, second stretch is identical to the nucleic acid coding for the functional tumor suppressor for which pathological cell is tumor suppressor-defective |
| 02/24/2005 | US20050043261 RNA of ribonucleoprotein U1 snRNP with a modification at the 5' end of its nucleotide sequence, is hybridized in at least one region of the 3' terminal exon of a target mRNA of the gene to be inactivated. |
| 02/24/2005 | US20050043260 cardiomyocyte differentiation from a non-cardiomyocyte cell; cardiac specific polynucleotide selected from Nkx2.5, GATA4, MEF2C, Tbx5, CRIPTO, NODAL, and cardiac myosin heavy chain |
| 02/24/2005 | US20050043259 Using transfer rna splicing endonuclease and oligonucleotide probes to preferentially locate, hybridize and split target messenger rna sequences comprising bulge-helix-bulge conformations |
| 02/24/2005 | US20050043257 administration of siRNA directed to IKK alpha to cells and SiRNA can be 21 to 25 nucleotides in length and hybridize to a nucleic acid molecule encoding human IKK alpha; for treating autoimmune and inflammatory disease in a mammal |
| 02/24/2005 | US20050043256 antisense oligonucleotides, are targeted to a nucleic acid encoding stearoyl-CoA desaturase, and modulate the expression of stearoyl-CoA desaturase; gene therapy; genetic engineering; for treatment of abnormal lipid metabolism, obesity |
| 02/24/2005 | US20050043254 contacting MT 0039 protein or the transformant expressing the protein with a candidate for screening an agent capable of controlling an activity of the protein |
| 02/24/2005 | US20050043241 Use of inhibitors of given amino acid sequence; inhibit phosphorylation of a transcription factor; can be used to treat or prevent diabetes, ionizing radiation damage, autoimmune diseases, ischemia/reperfusion injuries, heart hypertrophies, cancer |
| 02/24/2005 | US20050043198 A related nucleic acid, expression vector, host cell, and protein, the protein having a common epitope with the protease; the protease acts as an unspecific endopeptidase; cleaners also contain an amylase, cellulase, hemicellulase, oxidoreductase, or lipase; cosmetics |
| 02/24/2005 | US20050042756 Intergenic and intragenic integration sites for foreign gene expression in recombinant S. gordonii strains |
| 02/24/2005 | US20050042755 Bacterium for use as vehicle for gene transport and transfer to preferential organs or tissues; tissue engineering and targeted somatic transgenesis |
| 02/24/2005 | US20050042754 Induction of the formation of insulin-producing cells via gene transfer of pancreatic beta-cell-associated transcriptional factor |
| 02/24/2005 | US20050042752 Methods of inducing gene expression |
| 02/24/2005 | US20050042749 Dopaminergic neurons and proliferation-competent precursor cells for treating Parkinson's disease |
| 02/24/2005 | US20050042740 Using ligand conjugated matrix to isolate functional adenoassociated viral particles from solution |
| 02/24/2005 | US20050042738 Carbohydrate-associated proteins |
| 02/24/2005 | US20050042735 Metabolic engineering for enhanced production of chitin and chitosan in microorganisms |
| 02/24/2005 | US20050042732 Zinc finger-based drug-dependent gene regulation system |
| 02/24/2005 | US20050042731 Four helical bundle cytokine family polypeptide for use in treatment, diagnosis and prevention of infection, cardiovascular, metabolic, developmental, skin, bone, inflammatory and autoimmune disorders |
| 02/24/2005 | US20050042730 Gene screening method using nuclear receptor |
| 02/24/2005 | US20050042729 Expression vector comprising nucleotide sequences conding immunoglobulin/interferon fusion for use in targeting and treatment of liver disorders |
| 02/24/2005 | US20050042728 Isolated human Ras-like proteins, nucleic acid molecules encoding these human Ras-like proteins, and uses thereof |
| 02/24/2005 | US20050042727 UDP-N-acetylglucosamine: galactose-Beta 1,3-N-A-acetylgalactosamine-alpha-R/N-acetylglucosamine-Beta 1,3-N-acetylgalactosamine-alpha-R (GIcNAc to GalNac) Beta 1,6-N-acetylglucosaminyltransferase, C2/4GnT |
| 02/24/2005 | US20050042726 Nucleotide sequences coding functional fragment of viomycin gene cluster for use in treatment of tuberculosis |
| 02/24/2005 | US20050042724 Sodium-dependent phosphate cotransporter (NAPTR) for use tool in identifying modulators for treatment and prevention of cell proliferative, nervous system and cardiovascular disorders |
| 02/24/2005 | US20050042722 Isolated nucleic acid encoding enzyme; chimera gene expression; genetic engineering |
| 02/24/2005 | US20050042721 Compositions and methods for enhanced expression of recombinant polypeptides from a single vector using a peptide cleavage site |
| 02/24/2005 | US20050042718 Using transgenic cells to generate monoclonal antibodies for use in immunodiagnostics and tissue directed therapy |
| 02/24/2005 | US20050042717 Scorpion toxins |
| 02/24/2005 | US20050042702 Methods for predicting pregnancy outcome in a subject by hCG assay |
| 02/24/2005 | US20050042701 Bioconjugates; metabolites; kits; bioavailbility; pharmacokinetics |
| 02/24/2005 | US20050042685 Using bispecific antibodies comprising magnetic particle to separate and identify tumorigenic testicular tissue in solution |
| 02/24/2005 | US20050042683 Expression vector comprising nucleotide sequences coding serum response element receptor (SERB-2) for use in identifying modulator for prevention and treatment of nervous system disorders |
| 02/24/2005 | US20050042680 Single chain antigen-binding polypeptides for polymer conjugation |
| 02/24/2005 | US20050042673 Method and compositions for ordering restriction fragments |
| 02/24/2005 | US20050042671 Modulation of angiogenesis |
| 02/24/2005 | US20050042669 Combinatorial chemistry |
| 02/24/2005 | US20050042667 Expression vector comprising nucleotide sequences coding polypeptide for use in diagnosis, treatment and prevention of immune, hematopoietic, inflammatory and tumor diseases |
| 02/24/2005 | US20050042660 Using column comprised of silicon carbide wisker to generate polynucleotide populations substantially enriched for cellular RNA sequences |
| 02/24/2005 | US20050042659 Secreted soluble alpha2delta-2, alpha2delta-3, or alpha2delta-4 calcium channel subunit polypeptides and screening assays using same |
| 02/24/2005 | US20050042656 Room temperature elution of nucleic acids |
| 02/24/2005 | US20050042655 Using hematopoietoic regulatory related polypeptide (HEMA) for use in diagnosis, treatment and prevention of hematopoietic disorders |
| 02/24/2005 | US20050042653 Human transport protein homologs |
| 02/24/2005 | US20050042649 Arrayed biomolecules and their use in sequencing |
| 02/24/2005 | US20050042648 Vitro sorting method |
| 02/24/2005 | US20050042646 RNA interference suppresion of neurodegenerative diseases and methods of use thereof |
| 02/24/2005 | US20050042644 Mobility-modified nucleobase polymers and methods of using same |
| 02/24/2005 | US20050042641 In vivo high throughput selection of RNAi probes |
| 02/24/2005 | US20050042637 Pax-encoding vector and use thereof |
| 02/24/2005 | US20050042634 B. anthracis prevention and treatment: mutant B. anthracis lacking luxS activity and furanone inhibition of growth, AI-2 quorum sensing, and toxin production |
| 02/24/2005 | US20050042624 Tumor antigen |
| 02/24/2005 | US20050042620 RNA catalyst for cleaving specific RNA sequences |
| 02/24/2005 | US20050042619 Use of site-specific nicking endonucleases to create single-stranded regions and applications thereof |
| 02/24/2005 | US20050042618 Fluorescent resonance energy transfer probes |
| 02/24/2005 | US20050042616 Screening hepatocarcinoma-6 nucleotide sequences to identify mutagenic variation; determining sensitivity of individual to liver cancer; cancer diagnosis |
| 02/24/2005 | US20050042614 Point mutations; dipeptidyl-peptidase inhibitors; kits |
| 02/24/2005 | US20050042613 Nucleic acids having expression differentails between hepatoblastoma and normal liver |
| 02/24/2005 | US20050042610 Method and support for biological analysis using oligonucleotides comprising a marker capable of enzymatic activation |
| 02/24/2005 | US20050042609 Using variation in signal ratios from fluorescent probes to detect chromosomal aberration; prenatal diagnosis of genetic disorders |
| 02/24/2005 | US20050042603 Protein fusion comprising nuclear localization signal domain for use as tool to enhance gene transfer into cells: gene therapy and heterologous gene expression |
| 02/24/2005 | US20050042273 Covalently linking PDGF Nucleic Acid Ligand with a Non-Immunogenic, High Molecular Weight Compound or Lipophilic Compound to form a Complex; diagnostic and therapeutic agent; improving pharmacokinetic properties |
| 02/24/2005 | US20050042234 Method |
| 02/24/2005 | US20050042230 Administering respiratory syncytial virus G protein immunogen or fragment |
| 02/24/2005 | US20050042226 Treatment of chronic human viral hepatitis |
| 02/24/2005 | US20050042222 Methods of diagnosing thyroid carcinoma |